Citrobacter koseri: A species of gram-negative enterobacteria found in WATER; SEWAGE; SOIL; and FOOD. It can be present in any clinical specimen as an opportunistic pathogen.Citrobacter: A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.Escherichia: A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.Enterobacteriaceae Infections: Infections with bacteria of the family ENTEROBACTERIACEAE.Psoas Abscess: Abscess of the PSOAS MUSCLES resulting usually from disease of the lumbar vertebrae, with the pus descending into the muscle sheath. The infection is most commonly tuberculous or staphylococcal.Citrobacter freundii: A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen.Citrobacter rodentium: A species of gram-negative bacteria in the genus CITROBACTER, family ENTEROBACTERIACEAE. As an important pathogen of laboratory mice, it serves as a model for investigating epithelial hyperproliferation and tumor promotion. It was previously considered a strain of CITROBACTER FREUNDII.Hemiterpenes: The five-carbon building blocks of TERPENES that derive from MEVALONIC ACID or deoxyxylulose phosphate.Polyisoprenyl Phosphates: Phosphoric or pyrophosphoric acid esters of polyisoprenoids.Terpenes: A class of compounds composed of repeating 5-carbon units of HEMITERPENES.Dimethylallyltranstransferase: An enzyme that, in the pathway of cholesterol biosynthesis, catalyzes the condensation of isopentenyl pyrophosphate and dimethylallylpyrophosphate to yield pyrophosphate and geranylpyrophosphate. The enzyme then catalyzes the condensation of the latter compound with another molecule of isopentenyl pyrophosphate to yield pyrophosphate and farnesylpyrophosphate. EC 2.5.1.1.Mevalonic AcidEpidural Abscess: Circumscribed collections of suppurative material occurring in the spinal or intracranial EPIDURAL SPACE. The majority of epidural abscesses occur in the spinal canal and are associated with OSTEOMYELITIS of a vertebral body; ANALGESIA, EPIDURAL; and other conditions. Clinical manifestations include local and radicular pain, weakness, sensory loss, URINARY INCONTINENCE, and FECAL INCONTINENCE. Cranial epidural abscesses are usually associated with OSTEOMYELITIS of a cranial bone, SINUSITIS, or OTITIS MEDIA. (From Adams et al., Principles of Neurology, 6th ed, p710 and pp1240-1; J Neurol Neurosurg Psychiatry 1998 Aug;65(2):209-12)Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.Glycogen Debranching Enzyme System: 1,4-alpha-D-Glucan-1,4-alpha-D-glucan 4-alpha-D-glucosyltransferase/dextrin 6 alpha-D-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (EC 2.4.1.25) and amylo-1,6-glucosidase (EC 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-D-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-D-glucan. As a glucosidase it catalyzes the endohydrolysis of 1,6-alpha-D-glucoside linkages at points of branching in chains of 1,4-linked alpha-D-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.Glycogen Storage Disease Type III: An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent.Pancreatic alpha-Amylases: A subclass of alpha-amylase ISOENZYMES that are secreted into PANCREATIC JUICE.alpha-Cyclodextrins: Cyclic GLUCANS consisting of six (6) glucopyranose units linked by 1,4-glycosidic bonds.Metabolic Phenomena: The CHEMICAL PROCESSES that occur within the cells, tissues, or an organism and related temporal, spatial, qualitative, and quantitative concepts.Peptide Nucleic Acids: DNA analogs containing neutral amide backbone linkages composed of aminoethyl glycine units instead of the usual phosphodiester linkage of deoxyribose groups. Peptide nucleic acids have high biological stability and higher affinity for complementary DNA or RNA sequences than analogous DNA oligomers.Metabolic Engineering: Methods and techniques used to genetically modify cells' biosynthetic product output and develop conditions for growing the cells as BIOREACTORS.Industrial Microbiology: The study, utilization, and manipulation of those microorganisms capable of economically producing desirable substances or changes in substances, and the control of undesirable microorganisms.Bacteria: One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.Nucleic Acid Conformation: The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape.Nucleic Acid Hybridization: Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503)Privacy: The state of being free from intrusion or disturbance in one's private life or affairs. (Random House Unabridged Dictionary, 2d ed, 1993)Confidentiality: The privacy of information and its protection against unauthorized disclosure.Computer Security: Protective measures against unauthorized access to or interference with computer operating systems, telecommunications, or data structures, especially the modification, deletion, destruction, or release of data in computers. It includes methods of forestalling interference by computer viruses or so-called computer hackers aiming to compromise stored data.Periodicals as Topic: A publication issued at stated, more or less regular, intervals.Journal Impact Factor: A quantitative measure of the frequency on average with which articles in a journal have been cited in a given period of time.Informed Consent: Voluntary authorization, by a patient or research subject, with full comprehension of the risks involved, for diagnostic or investigative procedures, and for medical and surgical treatment.Publishing: "The business or profession of the commercial production and issuance of literature" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.Surgical Wound Infection: Infection occurring at the site of a surgical incision.Colorectal Surgery: A surgical specialty concerned with the diagnosis and treatment of disorders and abnormalities of the COLON; RECTUM; and ANAL CANAL.Cefotetan: A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.Drug Repositioning: The deliberate and methodical practice of finding new applications for existing drugs.Antibiotic Prophylaxis: Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications.Surgical Procedures, Elective: Surgery which could be postponed or not done at all without danger to the patient. Elective surgery includes procedures to correct non-life-threatening medical problems as well as to alleviate conditions causing psychological stress or other potential risk to patients, e.g., cosmetic or contraceptive surgery.Anastomotic Leak: Breakdown of the connection and subsequent leakage of effluent (fluids, secretions, air) from a SURGICAL ANASTOMOSIS of the digestive, respiratory, genitourinary, and cardiovascular systems. Most common leakages are from the breakdown of suture lines in gastrointestinal or bowel anastomosis.Azabicyclo Compounds: Bicyclic bridged compounds that contain a nitrogen which has three bonds. The nomenclature indicates the number of atoms in each path around the rings, such as [2.2.2] for three equal length paths. Some members are TROPANES and BETA LACTAMS.Ceftazidime: Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.Injections: Introduction of substances into the body using a needle and syringe.Product Labeling: Use of written, printed, or graphic materials upon or accompanying a product or its container or wrapper. It includes purpose, effect, description, directions, hazards, warnings, and other relevant information.Drug Interactions: The action of a drug that may affect the activity, metabolism, or toxicity of another drug.Injections, Intramuscular: Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.Triamcinolone Acetonide: An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.Solutions: The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed)Telomere: A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).Mars: The fourth planet in order from the sun. Its two natural satellites are Deimos and Phobos. It is one of the four inner or terrestrial planets of the solar system.Agar: A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.Bacteriological Techniques: Techniques used in studying bacteria.Urinary Catheterization: Passage of a CATHETER into the URINARY BLADDER or kidney.

Myocarditis in sibling boxer puppies associated with Citrobacter koseri infection. (1/23)

Two sibling Boxer puppies presented with severe suppurative myocarditis in the absence of additional disseminated suppurative foci. The identification of gram-negative bacteria within areas of myocarditis in both puppies and the pure growth of large numbers of Citrobacter koseri from the myocardial lesions in one of the dogs were consistent with a bacterial etiology. The fact that C. koseri is an opportunist pathogen suggested intercurrent immunosuppression. The finding of a concomitant bacterial myocarditis in two canine siblings is novel. The case is also unusual in that syncope could be related to the myocardial injury.  (+info)

Citrobacter koseri brain abscess in the neonatal rat: survival and replication within human and rat macrophages. (2/23)

A unique feature of Citrobacter koseri is the extremely high propensity to initiate brain abscesses during neonatal meningitis. Previous clinical reports and studies on infant rats have documented many Citrobacter-filled macrophages within the ventricles and brain abscesses. It has been hypothesized that intracellular survival and replication within macrophages may be a mechanism by which C. koseri subverts the host response and elicits chronic infection, resulting in brain abscess formation. In this study, we showed that C. koseri causes meningitis and brain abscesses in the neonatal rat model, and we utilized histology and magnetic resonance imaging technology to visualize brain abscess formation. Histology and electron microscopy (EM) revealed that macrophages (and not fibroblasts, astrocytes, oligodendrocytes, or neurons) were the primary target for long-term C. koseri infection. To better understand C. koseri pathogenesis, we have characterized the interactions of C. koseri with human macrophages. We found that C. koseri survives and replicates within macrophages in vitro and that uptake of C. koseri increases in the presence of human pooled serum in a dose-dependent manner. EM studies lend support to the hypothesis that C. koseri uses morphologically different methods of uptake to enter macrophages. FcgammaRI blocking experiments show that this receptor primarily facilitates the entry of opsonized C. koseri into macrophages. Further, confocal fluorescence microscopy demonstrates that C. koseri survives phagolysosomal fusion and that more than 90% of intracellular C. koseri organisms are colocalized within phagolysosomes. The ability of C. koseri to survive phagolysosome fusion and replicate within macrophages may contribute to the establishment of chronic central nervous system infection including brain abscesses.  (+info)

SHV-34: an extended-spectrum beta-lactamase encoded by an epidemic plasmid. (3/23)

OBJECTIVES: To elucidate the causes for treatment failure in children given extended-spectrum cephalosporins. METHODS: During April 1998-March 2000, 18 isolates of members of the family Enterobacteriaceae, fulfilling microbiological criteria for carriage of extended-spectrum beta-lactamases (ESBLs) and carrying blaSHV, were isolated from paediatric inpatients. The collection was subjected to a retrospective molecular analysis. RESULTS: Three species were represented in the collection: Citrobacter koseri (one isolate), Escherichia coli (one isolate) and Klebsiella pneumoniae (16 isolates). A common plasmid was found in these bacteria, as judged by restriction endonuclease digestion. This was able to transfer an ESBL phenotype from donors to a laboratory strain of E. coli. Nucleotide sequence analysis revealed that this phenotype was associated with a new variant in blaSHV encoding SHV-34. CONCLUSIONS: Analysis reveals the presence of an epidemic plasmid in this collection of bacteria. This carries a gene encoding the SHV-34 ESBL, described for the first time in this report. Nucleotide sequence analysis shows that there is a mutation from A-->G affecting the codon at amino acid position 64 (GAA-->GGA), changing the glutamic acid typically seen in this position to glycine.  (+info)

Citrobacter koseri and Citrobacter amalonaticus isolates carry highly divergent beta-lactamase genes despite having high levels of biochemical similarity and 16S rRNA sequence homology. (4/23)

OBJECTIVES: Isolates previously identified as Citrobacter diversus are now known as Citrobacter koseri. We measured sequence variation at the beta-lactamase structural gene among a group of clinical isolates originally identified as C. diversus by API 20E profiling. METHODS: beta-Lactamase and 16S rRNA genes were amplified by PCR and sequenced by standard methods. beta-Lactamase induction was attempted in liquid-grown cultures using cefoxitin. Nitrocefin hydrolysis assays were performed using a spectrophotometer. RESULTS: Analysis of 16S rRNA gene sequences showed that Citrobacter spp. isolates with an inducible beta-lactamase gene, cdiA, closely related to 'C. koseri ' NF85 and ULA27 are actually Citrobacter amalonaticus. C. koseri isolates, whose identities were confirmed by 16S rRNA sequencing, produce a class A beta-lactamase, Cko, constitutively at low levels. The cko and cdiA beta-lactamase genes share <45% identity. CONCLUSIONS: We have confirmed that cko is a beta-lactamase gene carried by C. koseri, and that isolates previously identified as 'C. koseri ', but carrying the cdiA beta-lactamase gene are C. amalonaticus. Thus, beta-lactamase-gene-specific PCR may provide a valuable tool to differentiate these biochemically homogeneous Citrobacter species.  (+info)

Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate. (5/23)

A new natural TEM derivative with extended-spectrum beta-lactamase activity, TEM-134, was identified in a ceftazidime-resistant clinical isolate of Citrobacter koseri. Compared to TEM-1, TEM-134 contains the following mutations: Q39K, E104K, R164H, and G238S. The bla(TEM-134) gene was not transferable by conjugation and, apparently, was chromosomally encoded. Expression studies with Escherichia coli revealed efficient cefotaximase and ceftazidimase activity for TEM-134.  (+info)

Diffuse pneumocephalus in neonatal Citrobacter meningitis. (6/23)

Pneumocephalus, intracranial air or gas collection, associated with neonatal meningitis is extremely rare. We report the first case in the United States and the second case in the world of intracranial gas accumulation in a neonate with Citrobacter koseri meningitis. The clinical presentation was acute with pneumocephalus demonstrated by cranial sonography and computed tomography. The clinical course was fatal despite the prompt administration of antibiotics.  (+info)

fliP influences Citrobacter koseri macrophage uptake, cytokine expression and brain abscess formation in the neonatal rat. (7/23)

Citrobacter koseri causes neonatal meningitis frequently complicated with multiple brain abscesses. During C. koseri central nervous system infection in the neonatal rat model, previous studies have documented many bacteria-filled macrophages within the neonatal rat brain and abscesses. Previous studies have also shown that C. koseri is taken up by, survives phagolysosomal fusion and replicates in macrophages in vitro and in vivo. In this study, in order to elucidate genetic and cellular factors contributing to C. koseri persistence, a combinatory technique of differential fluorescence induction and transposon mutagenesis was employed to isolate C. koseri genes induced while inside macrophages. Several banks of mutants were subjected to a series of enrichments to select for gfp : : transposon fusion into genes that are turned off in vitro but expressed when intracellular within macrophages. Further screening identified several mutants attenuated in their recovery from macrophages compared with the wild-type. A mutation within an Escherichia coli fliP homologue caused significant attenuation in uptake and hypervirulence in vivo, resulting in death within 24 h. Furthermore, analysis of the immunoregulatory interleukin (IL)-10/IL-12 cytokine response during infection suggested that C. koseri fliP expression may alter this response. A better understanding of the bacteria-macrophage interaction at the molecular level and its contribution to brain abscess formation will assist in developing preventative and therapeutic strategies.  (+info)

Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital. (8/23)

OBJECTIVES: Kinetic characterization of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant isolated from Citrobacter koseri during an Italian nationwide survey. TEM-134 is a natural derivative of TEM-2 with the following substitutions: E104K, R164H and G238S. METHODS: Recombinant TEM-134 was purified from Escherichia coli HB101 (pMGP-134) by three chromatographic steps (cation-exchange chromatography, gel permeation and fast chromatofocusing). Steady-state kinetic parameters (K(m) and k(cat)) were determined by measuring substrate hydrolysis under initial rate conditions using the Hanes linearization of the Michaelis-Menten equation. Modelling was carried out using the software Modeller (version 9.1). RESULTS: TEM-134 hydrolysed with variable efficiency (k(cat)/K(m) ranging from 5 x 10(3) to 8.0 x 10(5) M(-1) . s(-1)) penicillins, narrow-spectrum cephalosporins, cefepime, cefotaxime, ceftazidime and aztreonam, which appeared to be the best substrate. Molecular modelling of the enzyme indicated that the R164H substitution may result in a compromised omega loop in TEM-134 and this may be responsible for its narrower spectrum of activity. CONCLUSIONS: Kinetic data and molecular modelling suggested that R164H has a mild detrimental effect on the global activity of the enzyme.  (+info)

*Infective endocarditis

Citrobacter koseri was found in an immunocompetent adult. Neisseria bacilliformis was found in a patient with a bicuspid aortic ...

*Ofloxacin

Streptococcus pyogenes Aerobic Gram-negative microorganisms Citrobacter koseri (Citrobacter diversus) Enterobacter aerogenes ...

*Neonatal meningitis

... such as Citrobacter koseri and Cronobacter sakazakii for example. Ultrasounds are useful for early imaging to determine ...

*List of MeSH codes (B03)

Citrobacter MeSH B03.440.450.425.200.275 --- Citrobacter freundii MeSH B03.440.450.425.200.475 --- Citrobacter koseri MeSH ... Citrobacter MeSH B03.660.250.150.100.210 --- Citrobacter freundii MeSH B03.660.250.150.100.475 --- Citrobacter koseri MeSH ... B03.440.450.425.200.737 --- Citrobacter rodentium MeSH B03.440.450.425.260 --- Edwardsiella MeSH B03.440.450.425.260.340 --- ... B03.660.250.150.100.737 --- Citrobacter rodentium MeSH B03.660.250.150.160 --- Edwardsiella MeSH B03.660.250.150.160.340 --- ...

*Citrobacter

... species are differentiated by their ability to convert tryptophan to indole (C. koseri is the only citrobacter to ... V. Drelichman; J. D. Band (1985). "Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, ... Citrobacter is a genus of Gram-negative coliform bacteria in the Enterobacteriaceae family. The species C. amalonaticus, C. ... Citrobacter shows the ability to accumulate uranium by building phosphate complexes. These bacteria can be found almost ...

*Citrobacter koseri

"Citrobacter koseri". NCBI Taxonomy Browser. 545. Type strain of Citrobacter koseri at BacDive - the Bacterial Diversity ... Citrobacter koseri is a Gram-negative, nonspore-forming bacillus. It is a facultative anaerobe capable of aerobic respiration. ... McPherson C, Gal P, Ransom JL (2008). "Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm ... C. koseri may be identified in the walls of congested vessels, presence of the cavities resulting from the infection do not ...

*Urinary tract infection

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Cholera

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Traveler's diarrhea

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Meningococcal disease

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Chromobacteriosis infection

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Enterobacteriaceae

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ... Other disease-causing bacteria in this family include Enterobacter and Citrobacter. Members of the Enterobacteriaceae can be ...

*Betaproteobacteria

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*List of infectious diseases

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*List of parasites of humans

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Klebsiella aerogenes

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Typhoid fever

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Gonorrhea

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Neisseria meningitidis

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Plague (disease)

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*Paratyphoid fever

Citrobacter koseri/Citrobacter freundii. Lac−. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*ടൈഫോയ്ഡ് - വിക്കിപീഡിയ

Serratia marcescens (Serratia infection) · Citrobacter koseri/Citrobacter freundii. Lac-. H2S+. Salmonella enterica (ടൈഫോയ്ഡ്, ...

*Ceftolozane

In these same studies, ceftolozane-tazobactam exhibited MIC90 values of ,1 μg/mL for Escherichia coli, Citrobacter koseri, ...

*Ceftolozane/tazobactam

In these same studies, ceftolozane-tazobactam exhibited MIC90 values of ,1 μg/mL for Escherichia coli, Citrobacter koseri, ...

*ಜಠರ/ಜಠರೀಯ ಹುಣ್ಣು/ವ್ರಣ - ವಿಕಿಪೀಡಿಯ

Citrobacter koseri/Citrobacter freundii. Lac-. H2S+. *Salmonella enterica *Typhoid fever, Paratyphoid fever, Salmonellosis ...

*কলেরা - উইকিপিডিয়া

Serratia marcescens (Serratia infection) · Citrobacter koseri/Citrobacter freundii. Lac-. H2S+. Salmonella enterica (Typhoid ...
The genus Citrobacter was originally distinguished from other members of the Enterobacteriaceae by its ability to use citrate as a carbon source. Citrobacter infection is commonly reported in neonates and immunocompromised patients. Citrobacter koseri, formerly known as Citrobacter diversus, is best known as the cause of sepsis and meningitis leading to central nervous system (CNS) abscesses in neonates and young infants. The majority of cases are sporadic, with no clear source of infection. A significant number of the infants with abscesses die, and many sustain CNS damage. It adults, however, Citrobacter infection with central nervous system involvement is rare, and is usually associated with an underlying disorder. Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696) was isolated in 1983 in Maryland where it caused neonatal meningitis. ...
hello i was diagnosed recently to have a citrobacter koseri , and it was causing me a painfull UTI ... desapear but i still have the flude and in the last exam i still have citrobacter . what can i do? ...
ID A8AL20_CITK8 Unreviewed; 327 AA. AC A8AL20; DT 23-OCT-2007, integrated into UniProtKB/TrEMBL. DT 23-OCT-2007, sequence version 1. DT 27-SEP-2017, entry version 56. DE RecName: Full=2-keto-3-deoxygluconate permease {ECO:0000256,HAMAP-Rule:MF_00070}; DE Short=KDG permease {ECO:0000256,HAMAP-Rule:MF_00070}; GN Name=kdgT {ECO:0000256,HAMAP-Rule:MF_00070}; GN OrderedLocusNames=CKO_03092 {ECO:0000313,EMBL:ABV14183.1}; OS Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696). OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales; OC Enterobacteriaceae; Citrobacter. OX NCBI_TaxID=290338 {ECO:0000313,EMBL:ABV14183.1, ECO:0000313,Proteomes:UP000008148}; RN [1] {ECO:0000313,EMBL:ABV14183.1, ECO:0000313,Proteomes:UP000008148} RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC BAA-895 / CDC 4225-83 / SGSC4696 RC {ECO:0000313,Proteomes:UP000008148}; RG The Citrobacter koseri Genome Sequencing Project; RA McClelland M., Sanderson E.K., Porwollik S., Spieth J., Clifton ...
Sigma-Aldrich offers abstracts and full-text articles by [Shaharuddin Nor Hayati, Chee Loon Leong, Chidambaram Suresh Kumar, Christopher Lee].
Terpenoids, also known as isoprenoids, are a large class of natural products consisting of isoprene (C5) units. There are two biosynthetic pathways, the mevalonate pathway [MD:M00095] and the non-mevalonate pathway or the MEP/DOXP pathway [MD:M00096], for the terpenoid building blocks: isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). The action of prenyltransferases then generates higher-order building blocks: geranyl diphosphate (GPP), farsenyl diphosphate (FPP), and geranylgeranyl diphosphate (GGPP), which are the precursors of monoterpenoids (C10), sesquiterpenoids (C15), and diterpenoids (C20), respectively. Condensation of these building blocks gives rise to the precursors of sterols (C30) and carotenoids (C40). The MEP/DOXP pathway is absent in higher animals and fungi, but in green plants the MEP/DOXP and mevalonate pathways co-exist in separate cellular compartments. The MEP/DOXP pathway, operating in the plastids, is responsible for the formation of essential oil ...
Manual curation resolved these bifurcations and reduced the number of Citrobacter contigs from ∼1,400 to 10 (the largest curated contig is 2.55 Mb) (Fig. 3B). The final contigs are generally syntenous with the Citrobacter 30_2 strain draft genome (Broad Institute, Cambridge, MA) and the complete Citrobacter koseri ATCC BAA-895 genome (Washington University, St. Louis, MO). Consequently, the fragments were oriented and ordered by reference to the C. koseri genome to generate a final genome representation for the dominant strain, UC1CIT-i (Table S6 in Dataset S2). Of the ten genome gaps, eight are the rRNA-encoding regions that could not be resolved, one is within a prophage, and one is in the intergenic region between genes on contig ends that are adjacent in both isolate genomes.. Citrobacter species are facultative anaerobes from the family Enterobacteriaceae and are commonly found as commensals within the mammalian intestinal tract. Like Serratia, they have been frequently documented as ...
Major depression (MDD) is accompanied by higher serum IgM/IgA responses to LPS of Gram-negative bacteria, suggesting increased bacterial translocation and gut dysbiosis. Gut dysbiosis may occur in bipolar disorder (BD) and there are differences between MDD and BD type 1 (BP1) and -2 (BP2) in nitro-oxidative stress biomarkers associated with leaky gut. This study examines serum IgM/IgA responses directed to LPS of 6 Gram-negative bacteria in 29 BP1, 37 BP2, 44 MDD and 30 healthy individuals. MDD plus BD was best discriminated from controls by increased IgM/IgA responses to Pseudomonas aeruginosa. BP1 patients showed higher IgM responses to Morganella morganii as compared with MDD and BP2 patients. Patients with melancholia showed higher IgA responses to Citrobacter koseri as compared to controls and non-melancholic depression. The total score on the Hamilton Depression Rating Scale was significantly associated with IgA responses, especially C. koseri. IgG responses to oxidized low-density lipoprotein
Nosocomial infections in renal transplant patients: risk factors and treatment implications associated with urinary tract and surgical site infections.. Guideline for interpretation of Microbiology Lab Results Lim Kruy, MD (SHCH). Augmentin. 3. If the first choice. • UTI: use nitrofurantoin.Citrobacter Koseri. FAQ. Can you recommend an other treatment for this. Sorry to everybody for the length but this should help you. it is from Up to.Treatment Options for the Cardinal Symptoms of Disruptive Mood Dysregulation. length of treatment,. Symptoms of Disruptive Mood Dysregulation Disorder ...
Removes maltotriose and maltotetraose chains that are attached by 1,6-alpha-linkage to the limit dextrin main chain, generating a debranched limit dextrin.
Over a 6-month period, eight strains of Citrobacter diversus (Citrobacter koseri) resistant to extended-spectrum cephalosporins and monobactams were isolated from seven colonized and/or infected patients from the same intensive care unit. All strains harbored a single large conjugative plasmid which mediated an extended-spectrum beta-lactamase of the SHV-4 type (ceftazidimase phenotype; enzyme pI, 7.8; plasmid DNA hybridization with a blaSHV-specific probe). All strains were characterized by antibiotic resistance pattern analysis, beta-lactamase content analysis, plasmid profiling, ribotyping with EcoRI, and arbitrarily primed (AP)-PCR with primers O8 and O12. Among the eight C. diversus strains, strains Cd5 to Cd12, six isolates (isolates Cd6 to Cd11) were identical by all markers; one strain (strain Cd5) differed by two markers (antibiotype and AP-PCR pattern with primer O8), and the remaining strain (strain Cd12) differed by two other markers (ribotype and AP-PCR pattern with primer O12). Our ...
Excision is contraindicated in the early stages of brain abscess formation nad a capsule is formed and occasionally due to abscess loculation. Lahti, C.
Citrobacter is a genus of Gram-negative coliform bacteria in the Enterobacteriaceae family. The species C. amalonaticus, C. koseri, and C. freundii can use citrate as a sole carbon source. Citrobacter species are differentiated by their ability to convert tryptophan to indole (C. koseri is the only citrobacter to be commonly indole-positive), ferment lactose (C. koseri is a non-lactose fermentor), and use malonate. Citrobacter shows the ability to accumulate uranium by building phosphate complexes. These bacteria can be found almost everywhere in soil, water, wastewater, etc. They can also be found in the human intestine. They are rarely the source of illnesses, except for infections of the urinary tract and infant meningitis and sepsis. C. freundii strains have inducible ampC genes encoding resistance to ampicillin and first-generation cephalosporins. In addition, isolates of Citrobacter may be resistant to many other antibiotics as a result of plasmid-encoded resistance genes. LPSN ...
The main purpose of DiverSus is to conduct high-quality research in the areas of biodiversity, ecosystems and sustainability, in response to socially-relevant problems. Within this main objective are the following sub-objectives: ...
FDiversity is a free software developed by Fernando Casanoves, Julio Di Rienzo y Laura Pla, to estimate and analyse indexes of functional diversity. It also includes tools to compare the estimated index among a set of conditions using a built-in linear model facility ...
We recommend you register with your work email address. Many organizations have institutional access to GenomeWeb Premium content and this access is managed based on your email address ...
Citrobacter farmeri is a Gram-negative species of bacteria. Brenner, D. J.; Grimont, P. A. D.; Steigerwalt, A. G.; Fanning, G. R.; Ageron, E.; Riddle, C. F. (1993). "Classification of Citrobacteria by DNA Hybridization: Designation of Citrobacter farmeri sp. nov., Citrobacter youngae sp. nov., Citrobacter braakii sp. nov., Citrobacter werkmanii sp. nov., Citrobacter sedlakii sp. nov., and Three Unnamed Citrobacter Genomospecies". International Journal of Systematic Bacteriology. 43 (4): 645-658. doi:10.1099/00207713-43-4-645. ISSN 0020-7713. PMID 8240948. Tan, C. K.; Lai, C. C.; Lin, S. H.; Liao, C. H.; Huang, Y. T.; Hsueh, P. R. (2010). "Fatal Citrobacter farmeri Meningitis in a Patient with Nasopharyngeal Cancer". Journal of Clinical Microbiology. 48 (4): 1499-1500. doi:10.1128/JCM.00282-10. ISSN 0095-1137. PMC 2849549 . PMID 20181904. Bruckner DA, Colonna P, Glenn D, Abbott SL, Janda JM (1997). "Citrobacter farmeri bacteremia in a child with short-bowel syndrome". J Clin Microbiol. 35 (12): ...
Looking for online definition of Levinea diversus in the Medical Dictionary? Levinea diversus explanation free. What is Levinea diversus? Meaning of Levinea diversus medical term. What does Levinea diversus mean?
Citrobacter freundii appear as Gram-negative, rod-shaped bacteria that are 0.3-1 micrometer in diameter and 0.6-6 micrometers in length. Citrobacter have hair-like extensions, called flagella, that...
Sigma-Aldrich offers abstracts and full-text articles by [G Amicosante, A Oratore, N Franceschini, M Maccarrone, R Strom, M Galleni, J M Frère].
The Lower and Middle Ordovician of the Yangtze Platform, China, is characterized by a sedimentary succession dominated by carbonate rocks. Three sections spanning the Nantsinkuan/Lunshan, Fenhsiang, Hunghuayuan, and Dawan/Zitai formations, corresponding to the Tremadocian-Dapingian in age, have been sampled for high-resolution δ13C chemostratigraphy (542 samples in total). Our new δ13C data reveal five tie-points with the potential for global correlation: (1) a positive δ13C excursion in the lower Nantsinkuan Formation within the Tremadocian Rossodus manitouensis Zone; (2) an excursion with two peaks roughly within the late Tremadocian Paltodus deltifer Zone; (3) a positive δ13C shift in the lower Hunghuayuan Formation, within the early Floian Serratognathus diversus Zone; (4) a gradual positive δ13C shift in the late Floian, ranging from the uppermost S. diversus Zone to the basal Oepikodus evae Zone; (5) a minor negative shift in the lower Dawan/Zitai Formation, within the early ...
do you know any links/sites i can use as a reference or any info on citrobacter freundii that are scientific resources? im doing a microbiology research profile ...
Mono- and Stereopictres of 5.0 Angstrom coordination sphere of Arsenic atom in PDB 3bfd: Crystal Structure of the Class A Beta-Lactamase Sed-G238C Mutant From Citrobacter Sedlakii
Citrobacterek, Enterobacter, Klebsiella eta Escherichiarekin batera bakterio koliformeen multzoa osatzen du. Koliformeak hestean bizi diren bakterioak dira, ezaugarri biokimiko amankomunak dituztenak eta garrantzi handikoak ingurugiro-mikrobiologian, kutsadura fekalaren adierazleak baitira.. Citrobacter giza zein animalien hesteetan bizi da, baina egoera librean ere aurki daiteke (uretan, lur-zoruan...) Espezie batzuk oportunistak dira, gaixotasunak sortuz immunitate-sistema ahula dutenengan. Gaitzak eragiten dituenean gernu-infekzioak eta meningitis dira ohikoenak.. ...
Citrobacter, a Gram-negative enteric bacillus, is a rare cause of septicemia and meningitis, seldom reported beyond the neonatal period. It is characterized by a fulminant clinical course and a high incidence of complications, including brain abscess
This study aimed to investigated the prevalence and resistance pattern of different Citrobacter species phenotypically and genotypically to β-lactam and some most common antibiotics then evaluate the antibacterial activity of omega-3 extracted from flaxseed against isolates that harboring resistance genes. 19 Citrobacter isolates were isolated from100 stool and urine samples taken from patients attended to AL-Sadar Hospital during June-December 2016. Clinical samples were cultured on specific media, thereafter isolates were identified depending on morphological, biochemical characteristics and VITK-2. The results showed that the Citrobacter comprise 24% of isolated bacteria which divided into 11 (14.1%) were C. freundii, 5 (6.41%) C. kosaeri and C. farmeri were 3 (3.8%). The antagonistic activity was evaluated by observing a clear zone of inhibition growth, the results showed that all Citrobacter (100%) isolates were resistant to Ampicillin, cefoxitin and sensitive to Imipinim, also the ...
Citrobacter freundii ATCC ® 8090™ Designation: TypeStrain=True Application: Produces restriction endonuclease CfrAI Quality control strain Reference material Quality control strain for Sensititre products
Citrobacter freundii ATCC ® 8090™ Designation: TypeStrain=True Application: Produces restriction endonuclease CfrAI Quality control strain Reference material Quality control strain for Sensititre products

KEGG PATHWAY: Terpenoid backbone biosynthesis - Citrobacter koseriKEGG PATHWAY: Terpenoid backbone biosynthesis - Citrobacter koseri

Terpenoid backbone biosynthesis - Citrobacter koseri [ Pathway menu , Organism menu , Pathway entry , Download KGML , Show ...
more infohttp://www.genome.jp/kegg-bin/show_pathway?cko00900

Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696)Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696)

Citrobacter koseri, formerly known as Citrobacter diversus, is best known as the cause of sepsis and meningitis leading to ... This proteome is part of the Citrobacter koseri pan proteome (fasta) The genus Citrobacter was originally distinguished from ... Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696) was isolated in 1983 in Maryland where it caused neonatal ... Proteomes - Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696). Basket 0 ...
more infohttp://www.uniprot.org/proteomes/UP000008148

Citrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis--a case report. | Sigma-AldrichCitrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis--a case report. | Sigma-Aldrich

Citrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis--a case report.. [Shaharuddin Nor Hayati ... Paraspinal abscess and spondylodiscitis due to Citrobacter koseri is a very rare condition. We report a remarkable case of ... Citrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis in a patient who has successfully been ...
more infohttps://www.sigmaaldrich.com/catalog/papers/23082432

glgX - Glycogen debranching enzyme - Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696) - glgX gene & proteinglgX - Glycogen debranching enzyme - Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696) - glgX gene & protein

sp,A8AQY2,GLGX_CITK8 Glycogen debranching enzyme OS=Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696) OX=290338 ... Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696). ,p>This subsection of the ,a href="http://www.uniprot.org/ ... cellular organisms › Bacteria › Proteobacteria › Gammaproteobacteria › Enterobacterales › Enterobacteriaceae › Citrobacter › ...
more infohttps://www.uniprot.org/uniprot/A8AQY2

Citrobacter koseri sources of infection - Doctor answers on HealthcareMagicCitrobacter koseri sources of infection - Doctor answers on HealthcareMagic

... desapear but i still have the flude and in the last exam i still have citrobacter . what can i do? ... ... hello i was diagnosed recently to have a citrobacter koseri , and it was causing me a painfull UTI ... ... Is citrobacter Koseri in the urine hard to treat and if on an antibiotic will it clear up. Is it contageous to other people ... an infection called Citrobacter Koseri, the hospital do not seem to know too much about the infection or what ... more... ...
more infohttps://www.healthcaremagic.com/search/citrobacter-koseri-sources-of-infection

UniProt: A8AL20 CITK8UniProt: A8AL20 CITK8

The Citrobacter koseri Genome Sequencing Project; RA McClelland M., Sanderson E.K., Porwollik S., Spieth J., Clifton W.S., RA ... Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696). OC Bacteria; Proteobacteria; Gammaproteobacteria; ... Enterobacterales; OC Enterobacteriaceae; Citrobacter. OX NCBI_TaxID=290338 {ECO:0000313,EMBL:ABV14183.1, ECO:0000313,Proteomes: ...
more infohttp://www.genome.jp/dbget-bin/www_bget?uniprot:A8AL20_CITK8

Citrobacter koseri - WikipediaCitrobacter koseri - Wikipedia

"Citrobacter koseri". NCBI Taxonomy Browser. 545. Type strain of Citrobacter koseri at BacDive - the Bacterial Diversity ... Citrobacter koseri is a Gram-negative, nonspore-forming bacillus. It is a facultative anaerobe capable of aerobic respiration. ... McPherson C, Gal P, Ransom JL (2008). "Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm ... C. koseri may be identified in the walls of congested vessels, presence of the cavities resulting from the infection do not ...
more infohttps://en.wikipedia.org/wiki/Citrobacter_koseri

Citrobacter Koseri Causes & Reasons - SymptomaCitrobacter Koseri Causes & Reasons - Symptoma

Citrobacter Koseri Symptom Checker: Possible causes include Klebsiella. Check the full list of possible causes and conditions ... Citrobacter koseri [globalrph.com] koseri / Citrobacter freundii Lac H2S Salmonella enterica Typhoid fever, Paratyphoid fever, ... 290338 Full name Citrobacter koseri Definition Citrobacter koseri ATCC BAA-895 Annotation KOALA Taxonomy TAX [genome.jp] ... Citrobacter koseri, formerly known as Citrobacter diversus, is best known as the cause of sepsis and meningitis leading to ...
more infohttps://www.symptoma.com/en/ddx/citrobacter-koseri

Citrobacter freundii, citrobacter koseri nelle urineCitrobacter freundii, citrobacter koseri nelle urine

Isolation of ceftriaxone-resistant Citrobacter freundii CRCF has been associated with the citrobacter koseri nelle urine broad ... Its habitat includes the environment soil, citrobacter koseri nelle urine, Band JD, Band JD, water, Band JD. Both strains were ... Dublin virulence antigen-positive ; and 4 Citrobacter koseri nelle urine serovars that harbor an spv-type virulence plasmid. ... A Microbial Biorealm page on the genus Citrobacter freundii. The cavities are initially square in shape and not tense, but when ...
more infohttp://leonardimagery.com/citrobacter-koseri-nelle-urine

Citrobacter koseri Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) GENTAUR-58bce8d591a1f | GentaursearchCitrobacter koseri Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) GENTAUR-58bce8d591a1f | Gentaursearch

Citrobacter koseri Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) datasheet and description hight quality ... Citrobacter koseri Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE). Short name: Citrobacter koseri Ubiquinone ... Recombinant Citrobacter koseri Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE). Alternative names: 2-methoxy- ...
more infohttps://gentaursearch.com/product/human/1529519/citrobacter-koseri-ubiquinone-menaquinone-biosynthesis-methyltransferase-ubie-ubie.html

Bacterial Nucleic Acids Page 8Bacterial Nucleic Acids Page 8

Citrobacter koseri Frederiksen (ATCC® BAA-895D-5™) ATCC® Number: BAA-895D-5™ Strain Designations: Genomic DNA from Citrobacter ... Citrobacter freundii (Braak) Werkman and Gillen (ATCC® 8090D™) ATCC® Number: 8090D™ Strain Designations: Genomic DNA from ...
more infohttps://www.atcc.org/Products/Cells_and_Microorganisms/Bacteria/Bacterial_Nucleic_Acids.aspx?dsNav=Ro:90,Ns:Organism_Accepted_Name%7C101%7C1%7C

Proteins matched: PD026929 (PD026929) | InterPro | EMBL-EBIProteins matched: PD026929 (PD026929) | InterPro | EMBL-EBI

Citrobacter koseri. Loading... A0A080FK84 Uncharacterized protein. Escherichia coli 1-392-07_S4_C3. Loading... ...
more infohttp://www.ebi.ac.uk/interpro/ISignatureProteins?sig=PD026929&query=D

November 2009 - Volume 28 - Issue 11 : The Pediatric Infectious Disease JournalNovember 2009 - Volume 28 - Issue 11 : The Pediatric Infectious Disease Journal

Brain Abscesses Due to Citrobacter koseri in a Pair of Twins. Etuwewe, Onajite; Kulshrestha, Richa; Sangra, Meharpal; More ...
more infohttps://journals.lww.com/pidj/Abstract/2009/11000/href

Levaquin Oral Solution - FDA prescribing information, side effects and usesLevaquin Oral Solution - FDA prescribing information, side effects and uses

Citrobacter koseri. Citrobacter freundii. Enterobacter aerogenes. Enterobacter sakazakii. Klebsiella oxytoca. Morganella ...
more infohttps://www.drugs.com/pro/levaquin-oral-solution.html

Avycaz (Ceftazidime-avibactam for Injection): Side Effects, Interactions, Warning, Dosage & UsesAvycaz (Ceftazidime-avibactam for Injection): Side Effects, Interactions, Warning, Dosage & Uses

Citrobacter koseri *Enterobacter aerogenes *Morganella morganii *Providencia rettgeri *Providencia stuartii *Serratia ... Citrobacter freundii complex. Complicated Urinary Tract Infections (cUTI), including Pyelonephritis. Aerobic Bacteria. Gram- ... Citrobacter freundii complex, Proteus mirabilis, and Pseudomonas aeruginosa in patients 18 years or older. ... Citrobacter freundii complex, and Pseudomonas aeruginosa in patients 18 years or older. ...
more infohttps://www.rxlist.com/avycaz-drug.htm

Zosyn (Piperacillin and Tazobactam Injection): Side Effects, Interactions, Warning, Dosage & UsesZosyn (Piperacillin and Tazobactam Injection): Side Effects, Interactions, Warning, Dosage & Uses

Citrobacter koseri. Moraxella catarrhalis. Morganella morganii. Neisseria gonorrhoeae. Proteus mirabilis. Proteus vulgaris. ...
more infohttps://www.rxlist.com/zosyn-drug.htm

Ciprofloxacin Tablets - FDA prescribing information, side effects and usesCiprofloxacin Tablets - FDA prescribing information, side effects and uses

Citrobacter koseri. Citrobacter freundii. Enterobacter cloacae. Escherichia coli. Haemophilus influenzae. Haemophilus ... Citrobacter koseri, Citrobacter freundii, Pseudomonas aeruginosa, methicillin-susceptible Staphylococcus epidermidis, ... Citrobacter freundii, Pseudomonas aeruginosa, methicillin--susceptible Staphylococcus aureus, methicillin-susceptible ...
more infohttps://www.drugs.com/pro/ciprofloxacin-tablets.html

Table 4 - Real-Time Microbiology Laboratory Surveillance System to Detect Abnormal Events and Emerging Infections, Marseille,...Table 4 - Real-Time Microbiology Laboratory Surveillance System to Detect Abnormal Events and Emerging Infections, Marseille,...

Citrobacter koseri. 2013 Sep 17. Various strains isolated with same antibiotic-resistance profile. Additional investigations ...
more infohttps://wwwnc.cdc.gov/eid/article/21/8/14-1419-t4

DailyMed - MOXIFLOXACIN solution/ dropsDailyMed - MOXIFLOXACIN solution/ drops

Citrobacter freundii Citrobacter koseri Enterobacter aerogenes Enterobacter cloacae Escherichia coli Klebsiella oxytoca ...
more infohttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae77e219-8af9-4aa4-96d3-05c9726a1d3c
  • Paraspinal abscess and spondylodiscitis due to Citrobacter koseri is a very rare condition. (sigmaaldrich.com)
  • Citrobacter koseri (strain ATCC BAA-895 / CDC 4225-83 / SGSC4696) was isolated in 1983 in Maryland where it caused neonatal meningitis. (uniprot.org)
  • Citrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis--a case report. (sigmaaldrich.com)
  • We report a remarkable case of Citrobacter koseri bacteraemia complicated by paraspinal abscess and spondylodiscitis in a patient who has successfully been treated in our hospital. (sigmaaldrich.com)
  • C. koseri may act as an opportunistic pathogen in a variety of human infections. (wikipedia.org)